Page last updated: 2024-08-23

etoposide and abt-199

etoposide has been researched along with abt-199 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Chai, G; Fan, Y; Song, T; Wang, A; Wang, P; Yu, X; Zhang, Z1
Chamuleau, MED1
Brown, JR; Davids, MS; Fisher, DC; Ihuoma, U; Jacobson, CA; Lehmberg, TZ; Montegaard, J; Parry, EM; Pazienza, S; Renner, SK; Rogers, KA; Thompson, PA; Tyekucheva, S; Wang, Z; Wu, CJ1

Trials

1 trial(s) available for etoposide and abt-199

ArticleYear
Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome.
    Blood, 2022, 02-03, Volume: 139, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisone; Progression-Free Survival; Sulfonamides; Vincristine

2022

Other Studies

3 other study(ies) available for etoposide and abt-199

ArticleYear
Systems analysis of phosphorylation-regulated Bcl-2 interactions establishes a model to reconcile the controversy over the significance of Bcl-2 phosphorylation.
    British journal of pharmacology, 2019, Volume: 176, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Drug Screening Assays, Antitumor; Etoposide; Humans; Kinetics; Ligands; Models, Biological; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Surface Plasmon Resonance; Tumor Cells, Cultured

2019
Venetoclax Boosts Benefits of R-EPOCH in Aggressive B-Cell Lymphomas.
    The oncologist, 2020, Volume: 25 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Sulfonamides; Vincristine

2020
Dose-adjusted EPOCH-R plus venetoclax: a toxic bend in the road to improving R-CHOP?
    The Lancet. Haematology, 2021, Volume: 8, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Prednisone; Sulfonamides; Vincristine

2021